First Citizens, CIT Group to Merge
The all-stock merger of equals will create the 19th-largest bank in the U.S. by assets and the combined company will take the First Citizens name.
State Street, BNY Mellon Report Declining Profit
The two large custody banks grew assets under management while experiencing low-to-single-digit declines in earnings and revenue.
Daimler's Third-Quarter Acceleration May Be as Good as It Gets
The maker of Mercedes-Benz posted much better quarterly cash flows than expected, but in some ways is an industry outlier.
Pfizer Could Apply for Emergency Use of Covid Vaccine by Late November
Drug giant Pfizer said it could be ready to apply for emergency-use authorization of its Covid-19 vaccine by late November, assuming it receives positive efficacy and safety data from late-stage human trials.
Tab, Coca-Cola's Diet-Soda Pioneer, Is Going Away
The soda company's first diet cola was a pop-culture icon in the 1970s and early '80s, then faded after the launch of Diet Coke. Coca-Cola kept the brand going for decades to appease a fiercely devoted base.
Amazon Prime Day Accelerates Shift to Online Shopping
The two-day event propelled consumers to spend billions more online this week, kicking off an end-of-year shopping season that is expected to be dominated by e-commerce shopping.
NIH to Study Three Drugs in Treatment of Covid Patients
The National Institutes of Health is launching a late-stage clinical trial of three drugs-Johnson & Johnson's Remicade, Bristol-Myers Squibb's Orencia, and AbbVie Inc.'s investigational drug CVC-as treatments for severe Covid-19.
LVMH Is Firing on the One Cylinder That Matters
Take away Louis Vuitton and Christian Dior and the world's biggest luxury company looks down at heel. All that matters for now, though, is the rapid recovery of those two brands.
Blackstone Raises the Stakes in Wager on Science Buildings
Blackstone Group is extending its big bet on biotechnology and other life-science buildings, a hot field in the real-estate world that is heating up even more as scientists pursue a vaccine for Covid-19.
Battery maker Exide is plowing ahead with efforts to walk away from contaminated sites in 10 states through bankruptcy, over a challenge from authorities in California, home to some of the company's most toxic facilities.
(END) Dow Jones Newswires